| Genome-wide association study identifies five new schizophrenia loci Nature genetics 43 (10), 969-976, 2011 | 1867 | 2011 |
| Suicide risk in schizophrenia: learning from the past to change the future M Pompili, XF Amador, P Girardi, J Harkavy-Friedman, M Harrow, ... Annals of general psychiatry 6 (1), 1-22, 2007 | 428 | 2007 |
| Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naive schizophrenia patients J Nielsen, S Skadhede, CU Correll Neuropsychopharmacology 35 (9), 1997-2004, 2010 | 254 | 2010 |
| Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided? J Nielsen, CU Correll, P Manu, JM Kane The Journal of clinical psychiatry 74 (6), 20799, 2013 | 226 | 2013 |
| Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis B Galling, A Roldan, RE Nielsen, J Nielsen, T Gerhard, M Carbon, ... JAMA psychiatry 73 (3), 247-259, 2016 | 214 | 2016 |
| Psychiatrists’ attitude towards and knowledge of clozapine treatment J Nielsen, M Dahm, H Lublin, D Taylor Journal of psychopharmacology 24 (7), 965-971, 2010 | 206 | 2010 |
| Safety and tolerability of antipsychotic polypharmacy JA Gallego, J Nielsen, M De Hert, JM Kane, CU Correll Expert opinion on drug safety 11 (4), 527-542, 2012 | 192 | 2012 |
| Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta‐analysis and meta‐regression analysis B Galling, A Roldan, K Hagi, L Rietschel, F Walyzada, W Zheng, XL Cao, ... World Psychiatry 16 (1), 77-89, 2017 | 180 | 2017 |
| The validity of the schizophrenia diagnosis in the Danish Psychiatric Central Research Register is good P Uggerby, SD Østergaard, R Røge, CU Correll, J Nielsen Dan Med J 60 (2), A4578, 2013 | 167 | 2013 |
| Assessing QT interval prolongation and its associated risks with antipsychotics J Nielsen, C Graff, JK Kanters, E Toft, D Taylor, JM Meyer CNS drugs 25 (6), 473-490, 2011 | 165 | 2011 |
| Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles JI Goldstein, L Fredrik Jarskog, C Hilliard, A Alfirevic, L Duncan, ... Nature communications 5 (1), 1-9, 2014 | 163 | 2014 |
| Optimizing clozapine treatment J Nielsen, P Damkier, H Lublin, D Taylor Acta Psychiatrica Scandinavica 123 (6), 411-422, 2011 | 162 | 2011 |
| Augmentation of clozapine with a second antipsychotic–a meta‐analysis DM Taylor, L Smith, SH Gee, J Nielsen Acta Psychiatrica Scandinavica 125 (1), 15-24, 2012 | 146 | 2012 |
| Risk factors for ileus in patients with schizophrenia J Nielsen, JM Meyer Schizophrenia bulletin 38 (3), 592-598, 2012 | 141 | 2012 |
| Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far? R Røge, BK Møller, CR Andersen, CU Correll, J Nielsen Schizophrenia research 140 (1-3), 204-213, 2012 | 137 | 2012 |
| Abuse potential of pregabalin O Schjerning, M Rosenzweig, A Pottegård, P Damkier, J Nielsen CNS drugs 30 (1), 9-25, 2016 | 129 | 2016 |
| Consensus statement on the use of clozapine during the COVID-19 pandemic D Siskind, WG Honer, S Clark, CU Correll, A Hasan, O Howes, JM Kane, ... Journal of Psychiatry and Neuroscience 45 (3), 222-223, 2020 | 128 | 2020 |
| Worldwide differences in regulations of clozapine use J Nielsen, C Young, P Ifteni, T Kishimoto, YT Xiang, PFJ Schulte, ... CNS drugs 30 (2), 149-161, 2016 | 128 | 2016 |
| Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management S Fanoe, D Kristensen, A Fink-Jensen, HK Jensen, E Toft, J Nielsen, ... European heart journal 35 (20), 1306-1315, 2014 | 127 | 2014 |
| Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine-or olanzapine-treated patients with schizophrenia spectrum disorder: a randomized clinical … JR Larsen, L Vedtofte, MSL Jakobsen, HR Jespersen, MI Jakobsen, ... JAMA psychiatry 74 (7), 719-728, 2017 | 122 | 2017 |
Claus GraffProfessor, Aalborg UniversityVerified email at hst.aau.dk
